HWX-79877-36205 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-07
Dose 1 — Pfizer-BioNTech
2021-03-29
Dose 2 — Pfizer-BioNTech
2021-03-30
Registered in v-safe
2021-03-30
Survey response — days 1–6 daily, dose 2
MedDRA: Neuralgia, Pruritus — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Free text: Nerve pain and itching / burning

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-03
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-06-28
Survey response — 3 months, dose 2
MedDRA: Morning sickness, Pregnancy — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Pregnancy, morning sickness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-07	Pfizer-BioNTech
2	2021-03-29	Pfizer-BioNTech

Free text

Release 6 — days 1–6 daily, dose 2

2021-03-30

Systemic reaction (other): Nerve pain and itching / burning

Release 9 — 3 months, dose 2

2021-06-28

Symptoms: Pregnancy, morning sickness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Morning sickness	✓	✓	○
SD	Pregnancy	✓	✓	✓
SRO	Neuralgia	✓	✓	✓
SRO	Pruritus	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release